Lincare Recalls Fluorouracil IV Bags Due to Sterility Concerns
Lincare, Inc. is recalling Fluorouracil IV bags compounded by United Medical IV Center because the sterility of the product is not assured.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an intravenous medication, which poses a significant risk of serious injury or hospitalization if contaminated.
Plain-English summary
Lincare, Inc. is recalling Fluorouracil 4600mg / D5W 292 mL IV bags, compounded by United Medical IV Center in Little Rock, Arkansas. The recall was initiated because the sterility of the product is not assured.
The affected product was compounded on May 28, 2015, and has a discard after date of June 11, 2015. The recall is classified as FDA Class II.
Healthcare providers and patients should stop using the affected product and contact Lincare, Inc. for further instructions.
The recalled product
- Product
- Fluorouracil 4600mg / D5W 292 mL, Qty: 1 292 mL Bag, Rx Only. Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.
- Manufacturer
- Lincare, Inc.
- Category
- Drug — IV Infusion
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Compounded on 05/28/15
- Discard After: 06/11/15
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 54 recalled by Lincare, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 54 products in this recall →Related recalls
Same manufacturer · Lincare, Inc.
See all →- SevereLincare Recalls Ganciclovir Sodium Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SevereLincare Recalls Penicillin G Potassium IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SevereLincare Recalls Hydrocodone IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SevereLincare Recalls TPN 3:1 Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
- SevereLincare Recalls Ceftazidime IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-07-08
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePharmakon Recalls Fentanyl Citrate Injection Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereBaptist Health Recalls Clindamycin IV Bags Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
- HighFDA Recalls Compounded Fentanyl Citrate IV Bags Due to Sterility Concerns
FDA (Drugs) · 2025-02-26
- HighFDA Recalls OxyTOCIN IV Bags Due to Sterility Assurance Issues
FDA (Drugs) · 2023-08-09
- HighBaptist Health Recalls Milrinone IV Bags Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
- SeverePharmakon Recalls Hydromorphone IV Bags Due to Sterility Concerns
FDA (Drugs) · 2016-07-20